Eli Lilly, Novo Nordisk and Medicare
Digest more
Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.
Danish diabetes and obesity drug giant Novo Nordisk has agreed with the US Administration to lower drug prices beginning in ...
The White House is expected to announce a deal for lower prices of obesity drugs from Novo Nordisk and Eli Lilly on Thursday ...
Trump first announced that deals had been made to reduce the price of Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy GLP-1 ...
On November 4, 2025, just a day after Pfizer filed its suits against Novo Nordisk and Metsera, Novo Nordisk submitted an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback